These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 37793862)
21. Complement in hemolytic anemia. Brodsky RA Hematology Am Soc Hematol Educ Program; 2015; 2015():385-91. PubMed ID: 26637747 [TBL] [Abstract][Full Text] [Related]
22. [Current treatment of paroxysmal nocturnal hemoglobinuria and prospects for new therapeutic agents in the future]. Nishimura JI Rinsho Ketsueki; 2021; 62(5):378-387. PubMed ID: 34108318 [TBL] [Abstract][Full Text] [Related]
23. C3-mediated extravascular hemolysis in PNH on eculizumab: Mechanism and clinical implications. Notaro R; Sica M Semin Hematol; 2018 Jul; 55(3):130-135. PubMed ID: 30032749 [TBL] [Abstract][Full Text] [Related]
24. [Molecular genetics, biochemistry, and biology of PNH]. Kinoshita T Rinsho Ketsueki; 2017; 58(4):353-362. PubMed ID: 28484166 [TBL] [Abstract][Full Text] [Related]
25. Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature. Fattizzo B; Pasquale R; Bellani V; Barcellini W; Kulasekararaj AG Front Immunol; 2021; 12():791429. PubMed ID: 34899761 [TBL] [Abstract][Full Text] [Related]
26. Successful use of eculizumab in a pediatric patient treated for paroxysmal nocturnal hemoglobinuria. Bauters T; Bordon V; Robays H; Benoit Y; Dhooge C J Pediatr Hematol Oncol; 2012 Nov; 34(8):e346-8. PubMed ID: 22767128 [TBL] [Abstract][Full Text] [Related]
27. Small Paroxysmal Nocturnal Hemoglobinuria Clones in Autoimmune Hemolytic Anemia: Clinical Implications and Different Cytokine Patterns in Positive and Negative Patients. Fattizzo B; Giannotta J; Zaninoni A; Kulasekararaj A; Cro L; Barcellini W Front Immunol; 2020; 11():1006. PubMed ID: 32582157 [TBL] [Abstract][Full Text] [Related]
28. A Case of Paroxysmal Cold Hemoglobinuria Possessing Moderate Paroxysmal Nocturnal Hemoglobinuria-Type Erythrocytes. Sugimoto T; Masui E; Ohata S; Goto H; Tomita T; Hashimoto H; Bouike Y Am J Case Rep; 2021 Nov; 22():e933102. PubMed ID: 34819489 [TBL] [Abstract][Full Text] [Related]
29. Eculizumab and Beyond: The Past, Present, and Future of Complement Therapeutics. Patriquin CJ; Kuo KHM Transfus Med Rev; 2019 Oct; 33(4):256-265. PubMed ID: 31703946 [TBL] [Abstract][Full Text] [Related]
30. Discovering C3 targeting therapies for paroxysmal nocturnal hemoglobinuria: Achievements and pitfalls. Risitano AM; Peffault de Latour R; Marano L; Frieri C Semin Immunol; 2022 Jan; 59():101618. PubMed ID: 35764467 [TBL] [Abstract][Full Text] [Related]
31. Recent advances in biological and clinical aspects of paroxysmal nocturnal hemoglobinuria. Luzzatto L; Gianfaldoni G Int J Hematol; 2006 Aug; 84(2):104-12. PubMed ID: 16926130 [TBL] [Abstract][Full Text] [Related]
32. Complement-driven anemia: more than just paroxysmal nocturnal hemoglobinuria. Merrill SA; Brodsky RA Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):371-376. PubMed ID: 30504334 [TBL] [Abstract][Full Text] [Related]
34. Role of Complement in Autoimmune Hemolytic Anemia. Berentsen S Transfus Med Hemother; 2015 Sep; 42(5):303-10. PubMed ID: 26696798 [TBL] [Abstract][Full Text] [Related]